Search Results 481-490 of 18582 for alopecia

1. Head and neck cancers - Doctors and departments - Mayo Clinic

   ... Alopecia areata, Seborrheic dermatitis, Melasma, Vitiligo. Show more areas of focus for Ashley B. Wentworth, M.D.. Josh P. Wiedermann ...

2. A Study Of Radiation Dosimetry, Safety, And Tolerability Of Extended Lutetium (177Lu) Vipivotide Tetraxetan Treatment In Chemo-naïve Adults With Metastatic Castration-resistant Prostate Cancer

   * Participants must have recovered to ≤ Grade 2 from all clinically significant toxicities related to prior therapies except alopecia. Key exclusion ...

3. Head and neck cancers - Doctors and departments - Mayo Clinic

   ... Alopecia areata, Scarring alopecia, Tinea versicolor, Rosacea, Melasma, Vitiligo, Vascular malformation, Nonmelanoma skin cancer, Tuberous sclerosis ...

4. Head and neck cancers - Doctors and departments - Mayo Clinic

   ... Alopecia areata, Scarring alopecia, Tinea versicolor, Rosacea, Melasma, Vitiligo, Vascular malformation, Nonmelanoma skin cancer, Tuberous sclerosis ...

5. Head and neck cancers - Doctors and departments - Mayo Clinic

   ... Alopecia areata, Seborrheic dermatitis, Melasma, Vitiligo. Show more areas of focus for Ashley B. Wentworth, M.D.. Josh P. Wiedermann ...

6. Head and neck cancers - Doctors and departments - Mayo Clinic

   ... Alopecia areata, Melasma. Show more areas of focus for Ashley B. Wentworth, M.D.. Josh P. Wiedermann, M.D.. Otolaryngologist. Rochester ...

7. Head and neck cancers - Doctors and departments - Mayo Clinic

   ... Alopecia areata, Scarring alopecia, Tinea versicolor, Rosacea, Melasma, Vitiligo, Vascular malformation, Vascular anomaly, Nonmelanoma skin cancer, Tuberous ...

8. Molecularly Targeted Therapy In Treating Patients With BRAF Wild-type Melanoma That Is Metastatic - Mayo Clinic

   with ongoing alopecia of any grade will be eligible; Patient must have a life expectancy of >= 3 months, as estimated by the treating oncologist; Patient must ...

9. Sleep disorders - Doctors and departments - Mayo Clinic

   ... Alopecia areata, Rosacea, Melasma, Leukoplakia, Age spots, Oral ulcerative condition, Vulvar disorder, Facial volume loss. Show more areas of focus for ...

10. A Study To Evaluate The Safety, Pharmacokinetics, And Anti-tumor Activity Of LYT-200 Alone And Combined With Chemotherapy Or Tislelizumab To Treat Patients With Metastatic Solid Tumors - Mayo Clinic

    Low-grade (< Grade 3) toxicities, such as neuropathy from prior treatments, manageable electrolyte abnormalities and lymphopenia, alopecia and vitiligo are ...